These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6190949)

  • 1. Production of antibody against C3c epitopes which are inaccessible on native C3.
    Hansen O; Jensenius JC; Folkersen J; Brandslund I
    J Immunol Methods; 1983 Jul; 61(2):245-52. PubMed ID: 6190949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a monoclonal antibody MoAb bH6 reacting with a neoepitope of human C3 expressed on C3b, iC3b, and C3c.
    Garred P; Mollnes TE; Lea T; Fischer E
    Scand J Immunol; 1988 Mar; 27(3):319-27. PubMed ID: 2451273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of antigenic determinants specific for the split products of the third complement factor, C3.
    Sinosich MJ; Best N; Teisner B; Grudzinskas JG
    J Immunol Methods; 1982; 51(3):355-8. PubMed ID: 6180028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.
    Medicus RG; Melamed J; Arnaout MA
    Eur J Immunol; 1983 Jun; 13(6):465-70. PubMed ID: 6222909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c.
    Laursen SB; Thiel S; Teisner B; Holmskov U; Wang Y; Sim RB; Jensenius JC
    Immunology; 1994 Apr; 81(4):648-54. PubMed ID: 7518801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The quantitation of C3d by routine methods after the direct absorption of human plasma with anti-C3c.
    Mlynek Y; Nilsson M
    Acta Pathol Microbiol Immunol Scand C; 1985 Oct; 93(5):195-8. PubMed ID: 3936336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three rat monoclonal antibodies to human C3.
    Lachmann PJ; Oldroyd RG; Milstein C; Wright BW
    Immunology; 1980 Nov; 41(3):503-15. PubMed ID: 6161872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification by ELISA of erythrocyte-bound C3 fragments expressing C3d and/or C3c epitopes in patients with factor I deficiency and with autoimmune diseases.
    Møller Rasmussen J; Jepsen HH; Teisner B; Holmskov-Nielsen U; Rasmussen GG; Svehag SE
    Vox Sang; 1989; 56(4):262-9. PubMed ID: 2474900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breakdown of C3 after complement activation. Identification of a new fragment C3g, using monoclonal antibodies.
    Lachmann PJ; Pangburn MK; Oldroyd RG
    J Exp Med; 1982 Jul; 156(1):205-16. PubMed ID: 6177820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localisation of a group of antigenic sites in complement component C3, and identification of a new fragmentation pattern.
    Fontaine M; Sim RB
    Biochim Biophys Acta; 1984 Sep; 789(2):119-27. PubMed ID: 6206896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitope specificities and quantitative and serologic aspects of monoclonal complement (C3c and C3d) antibodies.
    Dobbie D; Brazier DM; Gardner B; Holburn AM
    Transfusion; 1987; 27(6):453-9. PubMed ID: 2446405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of C3 subcomponents on red cells coated with complement in vitro.
    Freedman J; Massey A
    J Clin Pathol; 1980 Oct; 33(10):977-83. PubMed ID: 7430364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of granulocyte histaminase release by particle-bound complement C3 cleavage products (C3b, C3bi) and IgG.
    Melamed J; Medicus RG; Arnaout MA; Colten HR
    J Immunol; 1983 Jul; 131(1):439-44. PubMed ID: 6223078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial characterization of physiologically generated C3 components expressing C3d but not C3c epitopes.
    Siersted HC; Jensenius JC; Svehag SE; Brandslund I
    J Clin Lab Immunol; 1983 Dec; 12(4):201-8. PubMed ID: 6198522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of fragments of the third component of human complement on erythrocytes by a new immunochemical method.
    Szymanski IO; Odgren PR
    Vox Sang; 1984; 46(2):92-101. PubMed ID: 6608178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The third complement factor (C3) and its in vivo cleavage products: interaction with lectins and precipitation with polyethylene glycol.
    Teisner B; Hau J; Svehag SE; Brandslund I; Bøg-Hansen TC
    J Immunol Methods; 1984 Jan; 66(1):113-8. PubMed ID: 6607289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of three monoclonal antibodies against C3 with selective specificities.
    Iida K; Mitomo K; Fujita T; Tamura N
    Immunology; 1987 Nov; 62(3):413-7. PubMed ID: 2444528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
    Aguado MT; Lambris JD; Tsokos GC; Burger R; Bitter-Suermann D; Tamerius JD; Dixon FJ; Theofilopoulos AN
    J Clin Invest; 1985 Oct; 76(4):1418-26. PubMed ID: 2932466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of a neoantigen on human C3bi and C3d by monoclonal antibody.
    Tamerius JD; Pangburn MK; Müller-Eberhard HJ
    J Immunol; 1985 Sep; 135(3):2015-9. PubMed ID: 2410510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of three anti-complement factor 3 monoclonal antibodies.
    Henwick S; Hetherington SV; Hostetter MK
    J Immunol Methods; 1992 Aug; 153(1-2):173-84. PubMed ID: 1517587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.